Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
Pneumococcal disease
2023
2020
Americas
Clear all
Type of publications
NITAG documentation
(76)
Systematic reviews (SYSVAC)
(4)
Topics
Available to download in languages
Regions
Americas
(80)
Africa
(11)
Eastern Mediterranean
(3)
Europe
(38)
South-East Asia
(4)
Western Pacific
(25)
Countries
Argentina
(1)
Canada
(14)
Chile
(10)
United States of America
(53)
Diseases
COVID-19
(72)
Meningococcal disease
(3)
Pneumococcal disease
(5)
Dengue
(1)
Diphtheria
(1)
Hepatitis A
(1)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(5)
Influenza
(6)
Pertussis
(1)
Poliomyelitis
(1)
RSV (Respiratory syncytial virus)
(5)
Tetanus
(1)
Vaccine topics
Acceptance
(2)
Coverage
(1)
Efficacy/effectiveness
(1)
Ethical issues
(1)
Target population
Adolescents
(1)
Adults
(2)
All age groups
(2)
Children
(1)
Healthcare workers
(2)
Newborn
(2)
Older adults
(2)
Risk group
(3)
Publication date
2023
(16)
2020
(64)
2024
(3)
2022
(44)
2021
(65)
2019
(8)
2018
(9)
2017
(2)
2016
(10)
2015
(6)
2014
(8)
2013
(6)
2012
(2)
2011
(3)
2010
(5)
2009
(1)
2008
(3)
2007
(2)
2006
(3)
2005
(1)
2004
(2)
2003
(3)
2002
(2)
1997
(2)
80 results found
2020
∙
Mary Chamberland, ACIP
Ethical Principles for Phased Allocation of COVID-19 Vaccines
2020
∙
Sara Oliver, ACIP
EtR Framework: Moderna COVID-19 vaccine
2020
∙
ACIP, Sara Oliver
EtR Framework: Public Health Problem, Resource Use and Equity Domains
2020
∙
Sara Oliver, ACIP
EtR Framework: Values, Acceptability and Feasibility Domains
2020
∙
Sara Oliver, ACIP
Evidence to Recommendations Framework: Pfizer-BioNTech COVID-19 vaccine
2020
∙
Julia Gargano, ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Moderna COVID-19 Vaccine
2020
∙
Julia Gargano, ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer BioNTech COVID-19 Vaccine
2020
∙
NACI, Public Health Agency of Canada
Guidance on the prioritization of initial doses of COVID-19 vaccine(s)
2020
∙
ACIP, Rachel Slayton
Modeling Allocation Strategies for the Initial SARS-CoV-2 Vaccine Supply
2020
∙
Matthew Biggerstaff, ACIP
Modeling Strategies for the Initial Allocation of SARS-CoV-2 Vaccines
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register